Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers

Benzer Materyaller

• Matrix Metalloproteinase Inhibitor, Marimastat, Decreases Peritoneal Spread of Gastric Carcinoma in Nude Mice
  Yazar:: Kimata, Masaru, ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• The matrix metalloproteinase inhibitor marimastat inhibits seizures in a model of kainic acid-induced status epilepticus
  Yazar:: Pijet, Barbara, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers
  Yazar:: Mant, Timothy G K, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
  Yazar:: Naik, Himanshu, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Variance of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) concentrations in activated, concentrated platelets from healthy male donors
  Yazar:: Hire, Justin M, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)